2024 Japan Hepatitis Diagnostic Testing for 10 Markers: Supplier Shares and Strategies, Volume and Sales Segment Forecasts for Immunodiagnostic and Molecular Diagnostic Procedures--Hospitals, Blood Banks, Commercial Labs, POC Locations
The report presents a detailed analysis of the Hepatitis diagnostics market in Japan. Current scientific views on the Hepatitis definition, epidemiology and etiology are reviewed.
The report is available by section, and can be customized to specific information needs and budget.
The report provides five-year test volume and sales forecasts for HAV NAT, HBV NAT, HBs Ag, HCV, HCV NAT, Anti-HBc, Anti-HBs, Anti-HAV, Hepatitis Delta, HBc Ag, HBe Ag, and ALT/SGPT tests performed in the following markets:
- Commercial/Private Labs
- Blood Banks
In addition to test volume and sales projections, the report presents sales and market share estimates for major suppliers of Hepatitis tests.
Also, the report examines the market applications of DNA Probes, Monoclonal Antibodies, Immunoassays, IT and other technologies; reviews features and operating characteristics of automated analyzers; profiles leading suppliers and recent market entrants developing innovative technologies and products; and identifies emerging business expansion opportunities, alternative market penetration strategies, market entry barriers and risks, and strategic planning issues and concerns.
Contains 241 pages and 14 tablesCompanies Profiled
- Beckman Coulter/Danaher
- Becton Dickinson
- Eiken Chemical
- Elitech Group
- Enzo Biochem
- GSK Biologicals
- Leica Biosystems
- Ortho-Clinical Diagnostics
- Siemens Healthineers
- Takara Bio
- Thermo Fisher